[Form 4] Snowflake Inc. Insider Trading Activity
Rhea-AI Filing Summary
Insider transactions by Snowflake director and President of Products Benoit Dageville: the filer used a 10b5-1 trading plan adopted March 28, 2025 to effect multiple transactions on 08/21/2025. The form shows an option exercise for 18,750 shares at a $13.48 exercise price, resulting in 18,750 underlying shares issued. The filer reported two disposals: a sale of 18,750 shares at $192.81 and a gift/disposition of 5,625 shares (code G) at $0. After the transactions, the reporting person beneficially owns 3,157,805 shares indirectly (held in The Snow Trust) and directly owns 77,075 shares including restricted stock units to vest; two GRAT trusts hold 750,000 shares each with one disclaimed. The stock option is fully vested and expires 12/10/2029.
Positive
- Transactions executed under a 10b5-1 plan (adopted 03/28/2025), indicating pre-planned trading and affirmative defense to insider trading claims
- Substantial indirect ownership remains: 3,157,805 shares held in The Snow Trust, showing continued alignment with shareholders
- Option was fully vested at exercise and has a stated expiration date of 12/10/2029, clarifying exercisability
Negative
- Disposition of shares: sale of 18,750 shares at $192.81 on 08/21/2025, which reduces direct holdings
- Gift/disposition of 5,625 shares (code G) on 08/21/2025, further decreasing direct ownership
Insights
TL;DR: Transactions largely routine: option exercise funded and contemporaneous sale under a 10b5-1 plan; substantial indirect holdings remain.
The reporting person exercised a fully vested option at $13.48 for 18,750 shares and sold 18,750 shares at $192.81 on 08/21/2025 pursuant to a 10b5-1 plan adopted 03/28/2025. The form also records a gift/disposition of 5,625 shares. Post-transactions, indirect beneficial ownership of 3,157,805 shares is significant and unchanged in control. The exercise-to-sale sequence is consistent with plan-based liquidity actions rather than ad hoc insider selling. No new material dilution or change in control is shown.
TL;DR: Disclosure is clear and includes 10b5-1 plan reference and trust holdings; signatures and explanations are properly noted.
The Form 4 discloses that transactions were effected under a documented 10b5-1 trading plan and explains trust ownership and disclaimers for GRAT-held shares. The reporting includes the required explanation lines for vested RSU issuance and identifies the option expiration date (12/10/2029). From a governance and compliance perspective, the filing meets standard disclosure expectations for an officer/director transaction.